Octave Bioscience is music to investors' wallets, raising $14 million in new funding for software the coordinate multiple sclerosis care.
https://medcitynews.com/2018/07/octave-bioscience-raises-14-million-for-ms-care-management-system-in-series-a-round/?rf=1&utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=64495567&_hsenc=p2ANqtz-91dH6WaUI8_hiP6q0AdpNLQ2RDHlZdkCh5GaygJKY61fjN0V8MvkjQYbKF2jxG4eK1GZhIMJCrQUbAbcmeXEKLluGFb1p1BBTKV6GScN-C8nZxDBo&_hsmi=64495567A study in Health Affairs examines reasons for variation in end-of-life cancer care.
Read More
An article in JAMA details the impact of a DOJ investigation on inappropriate use of implantable defibrillators.
Read More
A study from Avalere suggests that Medicare Advantage plans have lower hospital and ER use for patients with chronic conditions.
Read More
The most recent Government Accounting Office report on the 340B drug purchase program illustrates just how bad hospital abuse of it is.
Read More
The NVCA Venture Monitor gives an update on the always important topic of venture funding for new business. So far 2018 looks hot.
Read More
In a convoluted transaction, EHR and other health care software vendor Cerner is investing $266 million in Essence Holdings, which owns population health vendor Lumeris and operates primary care clinics. The companies will also work toward creation of a software product aimed at Medicare Advantage plans.
https://medcitynews.com/2018/07/cerner-lumeris/?utm_campaign=MCN%20Daily%20Top%20Stories&utm_source=hs_email&utm_medium=email&utm_content=64338012&_hsenc=p2ANqtz-_yZQfqQrwfFCMGn4pveRk1G_dtcgUMl63Ej2_dChEuu7vgrSbGRs0HU6GAjr-R7HrWiiKKIptCQwKkVa06XigAaKcXbwb5lbE7X3e5b4kRxoDQhZU&_hsmi=64338012&rf=1A new study indicates that "hospital-at-home" care can provide good outcomes and better patient satisfaction.
Read More
A study in Health Services Research compares Medicare Advantage's risk adjustment methodology with other measures of beneficiary health status.
Read More
